[1]Espasa M, González-Martín J, Alcaide F, et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J Antimicrob Chemother, 2005, 55(6): 860-865.[2]Ulger M, Aslan G, Emekdas G, et al. Investigation of rpsL and rrs gene region mutations in streptomycin resistant Mycobacterium tuberculosis complex isolates. Mikrobiyol Bul, 2009, 43(1):115-120.[3]Nhu NT, Lan NT, Phuong NT, et al. Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. Int J Tuberc Lung Dis, 2012, 16(4):527-531.[4]Zhang M, Gong J, Lin Y, et al. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun, 1998, 66(2):794-799.[5]Janagama HK, Hassounah HA, Cirillo SL, et al. Random inducible controlled expression (RICE) for identification of mycobacterial virulence genes. Tuberculosis(Edinb), 2011, 91 Suppl 1:S66-68.[6]Florczyk MA, McCue LA, Stack RF, et al. Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. Infect Immun, 2001, 69(9):5777-5785.[7]Kumar SG, Venugopal AK, Mahadevan A, et al. Quantitative proteomics for identifying biomarkers for tuberculous meningitis. Clin Proteomics, 2012, 9(1):12.[8]Wu WW, Wang G, Baek SJ, et al. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.J Proteome Res, 2006, 5(3):651-658.[9]Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol, 2005, 1(5):252-262.[10]Shui W, Gilmore SA, Sheu L, et al. Quantitative proteomic profiling of host-pathogen interactions: the macrophage response toMycobacterium tuberculosis lipids. J Proteome Res, 2009, 8(1):282-289.[11]Soudani A, Hadjfredj S, Zribi M, et al. Genotypic and phenotypic characteristics of tunisian isoniazid-resistant Mycobacterium tuberculosis strains. J Microbiol, 2011,49(3):413-417.[12]Yao C, Zhu T, Li Y, et al. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray. Clin Microbiol Infect, 2010, 16(11):1639-1643.[13]Tudó G, Rey E, Borrell S, et al. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. J Antimicrob Chemother, 2010, 65(11): 2341-2346.[14]Jiang X, Zhang W, Gao F,et al. Comparison of the proteome of isoniazid-resistant and susceptible- strains of Mycobacterium tuberculosis. Microb Drug Resist, 2006, 12(4): 231-238.[15]Sharma P, Kumar B, Gupta Y, et al. Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. Proteome Sci, 2010, 8:59.[16]Mehaffy C, Hess A, Prenni JE, et al. Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics, 2010, 10(10):1966-1984. |